Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
about
Vaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useVaccines for preventing rotavirus diarrhoea: vaccines in useFindings from a comprehensive diarrhoea prevention and treatment programme in Lusaka, ZambiaGlobal impact of rotavirus vaccines.Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China.Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine.Prevention and treatment of viral diarrhea in pediatrics.Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq.First reports of human rotavirus G8P[4] gastroenteritis in the United States.Rotavirus immune responses and correlates of protection.Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, BoliviaPublic health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis.Effect of human rotavirus vaccine on severe diarrhea in African infantsA critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix.Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi.Rotarix®: vaccine performance 6 years postlicensure.Rotavirus vaccine: a cost effective control measure for India.Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?Surveillance of rotavirus gastro-enteritis in children in Blantyre, Malawi.Rotavirus genotypes in children in the community with diarrhea in Madagascar.Rotarix in Japan: Expectations and ConcernsA mathematical model of the indirect effects of rotavirus vaccination.Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia
P2860
Q24197495-06385B14-52C3-45B6-96FC-F1AA2B6E3EB7Q24203645-E7C6F4DD-9B68-4FFA-8721-A483D27D741DQ24235411-A3FACF73-A70F-4940-9A7E-3474869C3AFAQ28601607-C3D0AE7A-F288-4E72-91F2-0371A0088174Q34108591-A8D8FCD4-6688-4603-B711-84CFED8876AAQ34271468-DE83051A-0087-4F27-A4BB-A1EC66283568Q34290838-7F400962-9B5E-4D4B-A82D-8DD2F537F020Q34616273-009D1502-C519-4D80-AA3D-71787688335AQ35806976-54793E33-9E55-4410-8DC1-C7E6ED53334CQ35807136-E90285F8-1B80-414B-A7A0-80FFDF040D5FQ36173819-BD4DA57A-4F0A-49BB-AB6E-F454761BA452Q36291026-4A4CF5AB-D729-45E8-A098-3EBDEE5DF934Q36455793-3E6D9CC8-19F0-4915-8F36-37DF687F8F21Q37363974-E29B4BFB-7B42-430C-AF7F-DCA6D1C2D448Q37425479-98CEBF24-E9C1-453C-9466-99286840F39FQ37547272-BBCC075C-46E4-4406-BC84-0F8743F6FA34Q37695267-0ABB6E1A-0813-4BE9-BE0C-90FED8350ACCQ37956376-6CAD9E03-4D17-4609-B4E5-7BC4813AB88DQ38052557-DAD6158D-2CD5-4A4E-80DE-51626C10E23FQ38068232-B7836F4A-B60B-4D58-9C42-4C74A618DA0FQ39452622-D5C3F940-16F4-4CEC-BEF6-35D91BEF2FF7Q41396305-77EEB546-955A-48D8-94AC-7B5016EFF7B3Q42775398-26B90C86-4428-421D-944A-17DA8EE5361EQ51764839-D3EC6338-0E30-444E-A479-053A30D1B5C0Q57097648-1C1EC0D2-9763-4B6C-9454-4EFCF38E5F55
P2860
Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Live attenuated human rotaviru ...... randomized controlled trials.
@en
Live attenuated human rotaviru ...... randomized controlled trials.
@nl
type
label
Live attenuated human rotaviru ...... randomized controlled trials.
@en
Live attenuated human rotaviru ...... randomized controlled trials.
@nl
prefLabel
Live attenuated human rotaviru ...... randomized controlled trials.
@en
Live attenuated human rotaviru ...... randomized controlled trials.
@nl
P2093
P1476
Live attenuated human rotaviru ...... randomized controlled trials.
@en
P2093
Alain Bouckenooghe
Beatrice De Vos
Brigitte Cheuvart
Htay Htay Han
Paul Gillard
Richard Ward
Serge Debrus
P304
P356
10.1097/INF.0B013E3181907177
P577
2009-04-01T00:00:00Z